Levels of ADAM10 are reduced in Alzheimer’s disease CSF

被引：0
|
作者：
Aitana Sogorb-Esteve
María-Salud García-Ayllón
Johan Gobom
Jordi Alom
Henrik Zetterberg
Kaj Blennow
Javier Sáez-Valero
机构：
[1] Universidad Miguel Hernández-CSIC,Instituto de Neurociencias de Alicante
[2] Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED),Servicio de Neurología, Hospital General Universitario de Elche
[3] Unidad de Investigación,Clinical Neurochemistry Laboratory
[4] Hospital General Universitario de Elche,Department of Neuroscience and Physiology
[5] Fundación para el Fomento de la Investigación Sanitaria Biomédica de la Comunidad Valenciana (FISABIO),Department of Molecular Neuroscience
[6] Fundación para el Fomento de la Investigación Sanitaria Biomédica de la Comunidad Valenciana (FISABIO),undefined
[7] Sahlgrenska University Hospital,undefined
[8] the Sahlgrenska Academy at the University of Gothenburg,undefined
[9] UCL Institute of Neurology,undefined
[10] UK Dementia Research Institute at UCL,undefined
来源：
Journal of Neuroinflammation | / 15卷
关键词：
Prodomain; Amyloid Precursor Protein (APP); ADAM10 Levels; ADAM10 Antibody; Ectodomain Antibody;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Levels of ADAM10 are reduced in Alzheimer's disease CSF
    Sogorb-Esteve, Aitana
    Garcia-Ayllon, Maria-Salud
    Gobom, Johan
    Alom, Jordi
    Zetterberg, Henrik
    Blennow, Kaj
    Saez-Valero, Javier
    JOURNAL OF NEUROINFLAMMATION, 2018, 15
  • [2] ADAM10 Plasma and CSF Levels Are Increased in Mild Alzheimer's Disease
    Pereira Vatanabe, Izabela
    Peron, Rafaela
    Mantellatto Grigoli, Marina
    Pelucchi, Silvia
    De Cesare, Giulia
    Magalhaes, Thamires
    Manzine, Patricia Regina
    Figueredo Balthazar, Marcio Luiz
    Di Luca, Monica
    Marcello, Elena
    Cominetti, Marcia Regina
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (05) : 1 - 13
  • [3] ADAM10 and Alzheimer's disease
    Emily Niemitz
    Nature Genetics, 2013, 45 (11) : 1273 - 1273
  • [4] α-secretase ADAM10 as well as αAPPs is reduced in platelets and CSF of Alzheimer disease patients
    Colciaghi, F
    Borroni, B
    Pastorino, L
    Marcello, E
    Zimmermann, M
    Cattabeni, F
    Padovani, A
    Di Luca, M
    MOLECULAR MEDICINE, 2002, 8 (02) : 67 - 74
  • [5] α-Secretase ADAM10 as Well as αAPPs Is Reduced in Platelets and CSF of Alzheimer Disease Patients
    Francesca Colciaghi
    Barbara Borroni
    Lucia Pastorino
    Elena Marcello
    Martina Zimmermann
    Flaminio Cattabeni
    Alessandro Padovani
    Monica Di Luca
    Molecular Medicine, 2002, 8 : 67 - 74
  • [6] The Role of ADAM10 in Alzheimer's Disease
    Yuan, Xiang-Zhen
    Sun, Sen
    Tan, Chen-Chen
    Yu, Jin-Tai
    Tan, Lan
    JOURNAL OF ALZHEIMERS DISEASE, 2017, 58 (02) : 303 - 321
  • [7] Nardilysin, ADAM10, and Alzheimer's disease: of mice and men
    Bernstein, Hans-Gert
    Steiner, Johann
    Bogerts, Bernhard
    Stricker, Rolf
    Reiser, Georg
    NEUROBIOLOGY OF AGING, 2014, 35 (03) : E1 - E1
  • [8] ADAM10 expression and promoter haplotype in Alzheimer's disease
    Bekris, Lynn M.
    Lutz, Franziska
    Li, Gail
    Galasko, Douglas R.
    Farlow, Martin R.
    Quinn, Joseph F.
    Kaye, Jeffrey A.
    Leverenz, James B.
    Tsuang, Debby W.
    Montine, Thomas J.
    Peskind, Elaine R.
    Yu, Chang-En
    NEUROBIOLOGY OF AGING, 2012, 33 (09)
  • [9] ADAM10 and alzheimer's disease: a study with brazilian elderly
    Manzine, P. R.
    Araujo, H. S. S.
    Vale, F. A. C.
    Barham, E. J.
    Cominetti, M. R.
    Pavarini, S. C., I
    27TH INTERNATIONAL CONFERENCE OF ALZHEIMER'S DISEASE INTERNATIONAL, 2012, : 97 - 100
  • [10] The role of ADAM10 in astrocytes: Implications for Alzheimer's disease
    Elsworthy, Richard J.
    Hill, Eric J.
    Dunleavy, Connor
    Aldred, Sarah
    FRONTIERS IN AGING NEUROSCIENCE, 2022, 14
12345